Statins and running: new study to reveal hidden effects on endurance athletes

NCT ID NCT07401017

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at how the cholesterol-lowering drug rosuvastatin affects fitness and muscle symptoms in people who run long distances at least three times a week. Researchers will compare runners taking rosuvastatin to those not taking it over three months, measuring changes in oxygen use and muscle discomfort. The goal is to understand if this statin interferes with endurance training or increases muscle problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Taipei medical university

    Taipei, 116, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.